1. Home
  2. NVCR vs PAYO Comparison

NVCR vs PAYO Comparison

Compare NVCR & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • PAYO
  • Stock Information
  • Founded
  • NVCR 2000
  • PAYO 2005
  • Country
  • NVCR Jersey
  • PAYO United States
  • Employees
  • NVCR N/A
  • PAYO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • PAYO EDP Services
  • Sector
  • NVCR Health Care
  • PAYO Technology
  • Exchange
  • NVCR Nasdaq
  • PAYO Nasdaq
  • Market Cap
  • NVCR 1.8B
  • PAYO 3.2B
  • IPO Year
  • NVCR 2015
  • PAYO N/A
  • Fundamental
  • Price
  • NVCR $17.49
  • PAYO $8.66
  • Analyst Decision
  • NVCR Buy
  • PAYO Strong Buy
  • Analyst Count
  • NVCR 5
  • PAYO 7
  • Target Price
  • NVCR $26.60
  • PAYO $8.93
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • PAYO 2.0M
  • Earning Date
  • NVCR 10-30-2024
  • PAYO 11-05-2024
  • Dividend Yield
  • NVCR N/A
  • PAYO N/A
  • EPS Growth
  • NVCR N/A
  • PAYO 447.53
  • EPS
  • NVCR N/A
  • PAYO 0.26
  • Revenue
  • NVCR $549,964,000.00
  • PAYO $900,058,000.00
  • Revenue This Year
  • NVCR $16.23
  • PAYO $14.06
  • Revenue Next Year
  • NVCR $6.09
  • PAYO $7.49
  • P/E Ratio
  • NVCR N/A
  • PAYO $32.93
  • Revenue Growth
  • NVCR 8.33
  • PAYO 21.43
  • 52 Week Low
  • NVCR $10.87
  • PAYO $4.22
  • 52 Week High
  • NVCR $24.74
  • PAYO $8.60
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • PAYO 81.47
  • Support Level
  • NVCR $15.61
  • PAYO $8.27
  • Resistance Level
  • NVCR $17.31
  • PAYO $8.56
  • Average True Range (ATR)
  • NVCR 1.29
  • PAYO 0.16
  • MACD
  • NVCR 0.05
  • PAYO 0.02
  • Stochastic Oscillator
  • NVCR 11.59
  • PAYO 100.00

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About PAYO Payoneer Global Inc.

Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started to empower global commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.

Share on Social Networks: